Detalhe da pesquisa
1.
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse.
Clin Lymphoma Myeloma Leuk
; 23(7): 535-544.e1, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37127471